Effect of 1α,25-dihydroxy vitamin D3 and vitamin E on insulin-induced glucose uptake in rat adipocytes

被引:21
作者
Huang, YN
Ishizuka, T
Miura, A
Kajita, K
Ishizawa, M
Kimura, M
Yamamoto, Y
Kawai, Y
Morita, H
Uno, Y
Yasuda, K
机构
[1] Gifu Univ, Sch Med, Dept Gen Med, Gifu 5008705, Japan
[2] Gifu Univ, Sch Med, Dept Internal Med 3, Gifu 5008705, Japan
关键词
1; alpha; 25-dihydroxy vitamin D3; vitamin E; insulin; glucose uptake; adipocytes; protein kinase C;
D O I
10.1016/S0168-8227(01)00324-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vitamin E, an antioxidant, improves insulin sensitivity through the suppression of conventional PKC in vascular smooth muscle cells. It has been reported that vitamin E reduces platelet aggregation through the suppression of PKCalpha and beta (Diabetes 47 (1998) 1494). On the other hand, 1alpha.25-dihydroxy vitamin D3 (1,25D3) activates conventional PKC and may subsequently cause insulin resistance. Against this background, we examined the effect of vitamin E and 1.25D3 on PKCbeta and PKC zeta/lambda activities in vitro and 10 nM insulin-induced glucose uptake in rat adipocytes. In vitro PKCbeta activity of adipocytes was slightly decreased by the addition of 1 muM vitamin E, but not PKC zeta/lambda activity. In contrast, a 10-1000 nM 1,25133 dose responsively activated PKCbeta activity of adipocytes (ED 50%. 10 nM), but not PKC zeta/lambda activity. Pretreatment with 1 muM vitamin E for 60 min did not improve the insulin-induced glucose uptake. On the other hand. pretreatment with a 10-1000 nM 1.25D3 dose responsively suppressed insulin-induced glucose uptake. Moreover, 1.25D3 increased membrane-associated PKCbeta immunoreactivity for 60 min, but no additional increase in membrane-associated PKCbeta immunoreactivity during treatment with insulin was observed. These results suggest that 1.25D3 reduces insulin-induced glucose uptake via activation of PKCbeta, but not vitamin E in rat adipocytes. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:175 / 183
页数:9
相关论文
共 32 条
[1]   THE PROTEIN-KINASE-C FAMILY [J].
AZZI, A ;
BOSCOBOINIK, D ;
HENSEY, C .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1992, 208 (03) :547-557
[2]   Specific cellular responses to α-tocopherol [J].
Azzi, A ;
Breyer, I ;
Feher, M ;
Pastori, M ;
Ricciarelli, R ;
Spycher, S ;
Staffieri, M ;
Stocker, A ;
Zimmer, S ;
Zingg, JM .
JOURNAL OF NUTRITION, 2000, 130 (07) :1649-1652
[3]   New model of atherosclerosis in insulin resistant sand rats:: hypercholesterolemia combined with D2 vitamin [J].
Bennani-Kabchi, N ;
Kehel, L ;
El Bouayadi, F ;
Fdhil, H ;
Amarti, A ;
Saidi, A ;
Marquié, G .
ATHEROSCLEROSIS, 2000, 150 (01) :55-61
[4]   ALPHA-TOCOPHEROL (VITAMIN-E) REGULATES VASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION AND PROTEIN-KINASE-C ACTIVITY [J].
BOSCOBOINIK, D ;
SZEWCZYK, A ;
AZZI, A .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1991, 286 (01) :264-269
[5]  
BOSCOBOINIK D, 1991, J BIOL CHEM, V266, P6188
[6]   STRUCTURE-FUNCTION-RELATIONSHIPS IN THE VITAMIN-D ENDOCRINE SYSTEM [J].
BOUILLON, R ;
OKAMURA, WH ;
NORMAN, AW .
ENDOCRINE REVIEWS, 1995, 16 (02) :200-257
[7]   1,25-(OH)2D3 modulates growth plate chondrocytes via membrane receptor-mediated protein kinase C by a mechanism that involves changes in phospholipid metabolism and the action of arachidonic acid and PGE2 [J].
Boyan, BD ;
Sylvia, VL ;
Dean, DD ;
Pedrozo, H ;
Del Toro, F ;
Nemere, I ;
Posner, GH ;
Schwartz, Z .
STEROIDS, 1999, 64 (1-2) :129-136
[8]   Vitamin E:: function and metabolism [J].
Brigelius-Flohé, R ;
Traber, MG .
FASEB JOURNAL, 1999, 13 (10) :1145-1155
[9]   INHIBITION OF SMOOTH-MUSCLE CELL-PROLIFERATION AND PROTEIN-KINASE-C ACTIVITY BY TOCOPHEROLS AND TOCOTRIENOLS [J].
CHATELAIN, E ;
BOSCOBOINIK, DO ;
BARTOLI, GM ;
KAGAN, VE ;
GEY, FK ;
PACKER, L ;
AZZI, A .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1176 (1-2) :83-89
[10]  
CHIN JE, 1993, J BIOL CHEM, V268, P6338